ArticleNucleic acids research2026
Deep learning-guided dual-fitness evolution of T7 RNA polymerase for enhanced stability and activity.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In protein engineering, simultaneously improving multiple fitness attributes is a critical yet challenging goal, largely due to the vastness of sequence space, the multifaceted interplay among different traits, and the complexity of non-linear mutational effects (epistasis). To address this, we developed a data-driven evolutionary strategy that couples in silico deep learning with a wet-lab multi-objective selection workflow. By employing independent model fine-tuning for distinct traits, our approach facilitates navigating the fitness landscape to identify beneficial mutation combinations. We applied this strategy to T7 RNA polymerase (T7 RNAP), performing dual-fitness evolution to simultaneously enhance thermostability and activity at elevated temperatures. After five rounds of iterative evolution, we obtained T7 RNAP mutants exhibiting a melting temperature (Tm) increase of >10°C, a 60-fold enhancement in high-temperature activity, and a 70% reduction in by-product content. Validation in cell transfection demonstrated their potential for producing high-quality mRNA for industrial applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.